"I spent four decades of my life wondering how to treat patients with Ebola. So this is the achievement of my life. " Dr Jean-Jacques Muyembe, who, together with his team of scientists, discovered a new treatment for Ebola that can cure symptoms in just an hour BBC.
Four drugs have recently been tested on patients in the Democratic Republic of Congo, where Ebola killed nearly 1,900 people in the last year.
It has been found that more than 90% of infected people can survive if treated early with the latest experimental drugs.
On Tuesday, two people cured of Ebola with experimental drugs were released from a treatment center in Goma, Democratic Republic of Congo, and met their families again.
According to the World Health Organization
(WHO), two other treatments called ZMapp and Remdesivir
used during the massive Ebola outbreak in Sierra Leone, Liberia and Guinea,
were withdrawn from research because new experimental drugs were the most
The DRC study, which began in November, has now been discontinued while all Ebola treatment units have been asked to use two experimental or monoclonal anti-antibody drugs.
"We will no longer say that Ebola is incurable," said Dr. Muyembe, who is also the director general of the Congolese National Institute for Biomedical Research, who oversaw the study. "These advances will save thousands of lives."
In the DRC, where there is a serious virus outbreak – the second largest – the biggest challenge in fighting the virus are frequent rebel attacks and high mobility of the population. According to experts, the suspicions of authorities and health agencies are also factors that impede efforts to stop the reaction.
Muyembe, who recently joined the scientists to announce
study results, it was said, news of the medicine may change the course of it
"Now we can say that 90 percent can get out of cured treatment, they will start believing it and they will gain trust," said the 77-year-old who was part of the team that discovered Ebola 43 years ago. "The first to provide this information will be the patients themselves."
Dr. Muyembe, referred to as the "real hero", has
have fought with Ebola since she first appeared in the DRC (then Zaire) in 1976.
At the age of 34 Muyembe was the first virologist to ever see the Ebola virus
patientand helped fight all nine explosions to strike
his country from now on.
He pioneered the use of survivors' blood serum – which contains antibodies – to save patients. The two experimental treatments that have recently proved effective are partly due to his original research, according to The New York Times.
When asked how he felt about it, he said, "I am
a bit sentimental. I had this idea a long time ago and waited patiently
because. I am very happy and I can't believe it. "
According BBC, new drugs called REGN-EB3 and mAb114 work by attacking the Ebola virus with antibodies, neutralizing its effect on human cells.
was developed using antibodies collected from survivors of Ebola, while REGN-EB3
comes from antibodies produced in disease-infected mice "
Dr. Anthony Fauci, director
from NIAID he said: "These are" the first drugs that are scientifically justified
studies have shown a marked reduction in mortality. "
From the patients listed
two experimental drugs in the study, 29% on REGN-EB3 and 34% on mAb114
died. Whereas 49% on ZMapp and 53% on Remdesivir (two earlier
treatment) died, according to NIAID.
The agency added it
survival rate among patients with low blood levels of the virus
was as high as 94% when they received REGN-EB3, and 89% when they received mAb114.
the findings mean that over 90% of people can survive if they undergo treatment
early, according to the team of scientists who worked on the sample.
The team also hopes that the deadly Ebola virus may soon become a preventable and treatable disease.
Why is Ebola dangerous?
Ebola disease (EVD) is a severe, often fatal disease in humans. It is often transmitted from animals to humans and then from humans to humans through direct contact with infected blood, body fluids or organs, or indirectly through contact with contaminated areas.
Formerly known as Ebola virus hemorrhagic fever, its name comes from the Ebola River in DRC. It was first discovered in 1976.
According to WHO, the incubation period of the disease is from two to 21 days. Some of the first symptoms are fever fatigue, muscle pain, headache and sore throat. Other symptoms include vomiting, diarrhea, rash, signs of kidney and liver problems, and in some cases internal and external bleeding.
People remain infected as long as their blood contains the virus and can also persist in a variety of fluids, including amniotic and placental fluids in pregnant women and breast milk in lactating women at the time of infection.